Karyopharm Therapeutics Inc Investor and Analyst Event at ASH Transcript
Good morning, everyone, and thank you all for joining us today for Karyopharm's Analyst Event at ASH. Following our webcast today, the slides being presented here will be made available on the Investors section of our website. I'm joined today by my colleague, Richard Paulson, President and CEO; Dr. Reshma Rangwala, Chief Medical Officer. I'm also very pleased to be joined today by 2 recognized global thought leaders in the area of MPN, Dr. Verstovsek and Dr. Ali.
On this slide is an outline of what we will cover today. Before we begin, I'd like to remind you that various remarks we'll make today constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 as outlined here.
It is now my pleasure to introduce Richard Paulson, President and CEO of Karyopharm. Richard?
Thank you, Elhan, and good morning to everyone. And we are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |